LCI 1477 (Diethylpropion Hydrochloride Extended Release 75 mg)
Pill with imprint LCI 1477 is White, Capsule-shape and has been identified as Diethylpropion hydrochloride extended release 75 mg. It is supplied by Lannett Company, Inc..
Diethylpropion is used in the treatment of obesity and belongs to the drug classes anorexiants, CNS stimulants. There is no proven risk in humans during pregnancy. Diethylpropion 75 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
Images for LCI 1477
Diethylpropion hydrochloride extended release
- Imprint:
- LCI 1477
- Strength:
- 75 mg
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Anorexiants
CNS stimulants - Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- 4 - Some potential for abuse
- Labeler / Supplier:
- Lannett Company, Inc.
- Inactive Ingredients:
- mannitol
carbomer homopolymer type A
tartaric acid
hypromellose acetate succinate 06081224 (3 mm2/s)
povidone k30
magnesium stearate
Note: Inactive ingredients may vary.
More about diethylpropion
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 123 Reviews – Add your own review/rating
- Drug class: anorexiants
Consumer resources
- Diethylpropion
- Diethylpropion Controlled-Release Tablets
- Diethylpropion Tablets
- Diethylpropion (Advanced Reading)
Other brands: Tenuate, Tenuate Dospan
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
